- 2 Drug Combination Stocks Targeting Leukemia
- Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
- Threshold TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
- Vivus' Drug Qnexa - May Be A Step Closer To Approval?
- The Hepatitis C Gold Rush - Looking For The Right Fit For Idenix's Drug IDX184
EXPstocktrader
EXPstocktrader
Send Message
EXPstocktrader
Stop FollowingEXPstocktrader
ABOUT
Former Wall Street Trader (EF Hutton / Shearson Lehman / Morgan Stanley / Prudential)
New to Seeking Alpha to help the small to mid-level investor through the treacherous waters controlled by HF's.
The editor of this blog has been trading stocks for over 30 years. His first few great stock picks while employed on Wall Street in the late 80's were Price Club, IGT, MGM, US Surgical, Columbia Pictures, New Line Cinema, and Home Depot. He started in the investment industry as an Intern for EF Hutton and moved into his first corporate office at Shearson Lehman Hutton and was a Growth Stock Advisor for the Los Angeles region and a Financial Consultant managing multi-millions in assets for over 1,100+ clients. ...More He was promoted to Vice President in his mid-20's where he worked at top Wall Street firms like Prudential Securities and later on as a Vice President with Dean Witter (now known as Morgan Stanley) before starting his own Investment Consulting Firm coordinating start-ups, advising publicly traded companies on strategy, making markets in stocks arranged through attorneys specializing solely in securities, and working with super high net worth investors.
A key strategy is following the Highly Capitalized, Big Money, Investors, Traders, VC's, Institutions, and Hedge Funds like: FMR (Fidelity Management and Research), Appaloosa Management, BlackRock, Highland Capital Partners, Kohlberg Kravis Roberts, Cerberus Capital, Citadel, George Soros, John Paulson, Duquesne Capital, David Tepper, Wilbur Ross, Carlos Slim Helu, Carl Icahn, Paul Tudor Jones II, Goldman Sachs, UBS, Barclays, Deutsche Bank, Credit Suisse, JPMorgan Chase, QVT, Rothschild, BlackStone, Brandes Investment Partners, and others.
In Summary: EXP is an experienced investment blogger and stock strategist following innovative financial information and dedicated to discovering and featuring emerging growth stocks to the investing public. Each company discovered has a very unique product or niche, and is usually in extremely high demand. The objective as an online research service is to help traders and investors like you make money by providing public awareness on those companies that we feel have tremendous growth potential as the companies that we uncover continue to expand and develop. Please follow us on Twitter @EXPstocktrader or http://www.EXPstocktrader.com
Disclosure: The administrator(s) of this board/blog/medium may be long, short, or flat in any position mentioned. All statements are made without any representation to its complete accuracy and administrator(s) are not compensated for posting notes. Prices shown are approximate. Ratings may change at any time. All posts are for simulation purposes only. All stock trades transacted by you are at your own risk. Please take any information that you see here and consult your own investment advisor before making any trades. We are not licensed to give you investment advice based on your own personal suitability and risk tolerances.
New to Seeking Alpha to help the small to mid-level investor through the treacherous waters controlled by HF's.
The editor of this blog has been trading stocks for over 30 years. His first few great stock picks while employed on Wall Street in the late 80's were Price Club, IGT, MGM, US Surgical, Columbia Pictures, New Line Cinema, and Home Depot. He started in the investment industry as an Intern for EF Hutton and moved into his first corporate office at Shearson Lehman Hutton and was a Growth Stock Advisor for the Los Angeles region and a Financial Consultant managing multi-millions in assets for over 1,100+ clients. ...More He was promoted to Vice President in his mid-20's where he worked at top Wall Street firms like Prudential Securities and later on as a Vice President with Dean Witter (now known as Morgan Stanley) before starting his own Investment Consulting Firm coordinating start-ups, advising publicly traded companies on strategy, making markets in stocks arranged through attorneys specializing solely in securities, and working with super high net worth investors.
A key strategy is following the Highly Capitalized, Big Money, Investors, Traders, VC's, Institutions, and Hedge Funds like: FMR (Fidelity Management and Research), Appaloosa Management, BlackRock, Highland Capital Partners, Kohlberg Kravis Roberts, Cerberus Capital, Citadel, George Soros, John Paulson, Duquesne Capital, David Tepper, Wilbur Ross, Carlos Slim Helu, Carl Icahn, Paul Tudor Jones II, Goldman Sachs, UBS, Barclays, Deutsche Bank, Credit Suisse, JPMorgan Chase, QVT, Rothschild, BlackStone, Brandes Investment Partners, and others.
In Summary: EXP is an experienced investment blogger and stock strategist following innovative financial information and dedicated to discovering and featuring emerging growth stocks to the investing public. Each company discovered has a very unique product or niche, and is usually in extremely high demand. The objective as an online research service is to help traders and investors like you make money by providing public awareness on those companies that we feel have tremendous growth potential as the companies that we uncover continue to expand and develop. Please follow us on Twitter @EXPstocktrader or http://www.EXPstocktrader.com
Disclosure: The administrator(s) of this board/blog/medium may be long, short, or flat in any position mentioned. All statements are made without any representation to its complete accuracy and administrator(s) are not compensated for posting notes. Prices shown are approximate. Ratings may change at any time. All posts are for simulation purposes only. All stock trades transacted by you are at your own risk. Please take any information that you see here and consult your own investment advisor before making any trades. We are not licensed to give you investment advice based on your own personal suitability and risk tolerances.
SNAPSHOT
- Description: Independent trader. Trading frequency: Weekly
- Interests: Options, Stocks - long, Stocks - short
COMPANY
BLOG
EXPstocktrader
We are an innovative online financial information source dedicated to discovering and featuring emerging growth stocks to the investing public. Each company discovered has a very unique product or niche, and is usually in extremely high demand. Our objective as an online magazine is to help traders and ...More
investors like you make money by providing public awareness on those companies that we feel have tremendous growth potential as the companies that we uncover continue to expand and develop.
Book
Currently, there are no book details for EXPstocktrader.
LATEST STOCKTALK
more »
Latest Comments
more »
- BofA / Merrill Lynch upgrad... on Idenix Pharmaceuticals (IDIX) moves up 5.2% pre...
- I am currently flat in stoc... on $BKS Chart - Short Squeeze Set Up
- For those who want to follo... on $BKS Chart - Short Squeeze Set Up
- Cheniere Energy $LNG is a s... on Reasons to Bet Big on Liquefied Natural Gas
- www.9news.com/news/art...- on Reasons to Bet Big on Liquefied Natural Gas
Latest comments on EXPstocktrader's Articles
more »
- TopDogInvesting on 2 Drug Combination Stocks Targeting Leukemia
- TriciaD on 2 Drug Combination Stocks Targeting Leukemia
- fermonzor on Threshold Pharmaceutical's TH-302 Could Be A Bl...
- ArtLvr on Threshold Pharmaceutical's TH-302 Could Be A Bl...
- ArtLvr on Threshold Pharmaceutical's TH-302 Could Be A Bl...
LATEST ARTICLES & INSTAPOSTS
more »


